VM2: Novel therapies in animal health – Balancing guidance versus gaining flexibility

By Mel Munro2022-12-05T00:04:00

5M4A2062_TOPRA Symposium 2022_Day 2_20221018

The new EU Veterinary Medicines Regulation contains specific provision for novel therapies. Established methodologies for demonstrating quality, safety and efficacy of veterinary medicinal products often cannot be applied to novel therapies.

This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

Not a TOPRA member yet?

Join now to get access to:

Features and specialist articles
CPD supplements
Comprehensive archive

Become a member today!

Not sure yet? Read one of our free editorials to see what you’re missing out on!